PAVmed Inc. Revenue from Contract with Customer, Including Assessed Tax
PAVmed Inc. (PAVM) reported Revenue from Contract with Customer, Including Assessed Tax of $166.00 thousand for the 3-month period ending 2023-06-30, per its 10-Q filed 2023-08-14.
Discontinued › Income Statement
us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax · last filed 2023-08-14
- PAVmed Inc. revenue from contract with customer, including assessed tax for the quarter ending 2023-06-30 was $166.00K.
- PAVmed Inc. revenue from contract with customer, including assessed tax for the quarter ending 2023-03-31 was $446.00K, a 135.98% increase year-over-year.
- PAVmed Inc. revenue from contract with customer, including assessed tax for the quarter ending 2022-12-31 was $112.00K, a 62.67% decline year-over-year.
- PAVmed Inc. revenue from contract with customer, including assessed tax for the quarter ending 2022-09-30 was $76.00K, a 62.00% decline year-over-year.
- PAVmed Inc. revenue from contract with customer, including assessed tax for fiscal 2022 was $377.00K, a 24.60% decline from fiscal 2021.
- PAVmed Inc. revenue from contract with customer, including assessed tax for fiscal 2021 was $500.00K.
| Period end | Revenue from Contract with Customer, Including Assessed Tax 3 month | Revenue from Contract with Customer, Including Assessed Tax 6 month | Revenue from Contract with Customer, Including Assessed Tax 9 month | Revenue from Contract with Customer, Including Assessed Tax 12 month |
|---|---|---|---|---|
| 2023-06-30 | $166.00K 10-Q · filed 2023-08-14 | $612.00K 10-Q · filed 2023-08-14 | $724.00K derived: sum of 3 quarters · filed 2023-08-14 | $800.00K derived: sum of 4 quarters · filed 2023-08-14 |
| 2023-03-31 | $446.00K 10-Q · filed 2023-05-15 | $558.00K derived: sum of 2 quarters · filed 2023-05-15 | $634.00K derived: sum of 3 quarters · filed 2023-05-15 | $634.00K derived: sum of 4 quarters · filed 2023-05-15 |
| 2022-12-31 | $112.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-14 | $188.00K derived: sum of 2 quarters · filed 2023-03-14 | $188.00K derived: sum of 3 quarters · filed 2023-03-14 | $377.00K 10-K · filed 2023-03-14 |
| 2022-09-30 | $76.00K 10-Q · filed 2022-11-14 | $76.00K derived: sum of 2 quarters · filed 2022-11-14 | $265.00K 10-Q · filed 2022-11-14 | $565.00K derived: sum of 4 quarters · filed 2023-05-15 |
| 2022-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-15 | $189.00K 10-Q · filed 2022-08-15 | $489.00K derived: sum of 3 quarters · filed 2023-05-15 | $689.00K derived: sum of 4 quarters · filed 2023-05-15 |
| 2022-03-31 | $189.00K 10-Q · filed 2023-05-15 | $489.00K derived: sum of 2 quarters · filed 2023-05-15 | $689.00K derived: sum of 3 quarters · filed 2023-05-15 | |
| 2021-12-31 | $300.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-14 | $500.00K derived: sum of 2 quarters · filed 2023-03-14 | $500.00K 10-K · filed 2023-03-14 | |
| 2021-09-30 | $200.00K 10-Q · filed 2022-11-14 | $200.00K 10-Q · filed 2022-11-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| InspireMD, Inc. (NSPR) | $0.033B | ||
| Glucotrack, Inc. (GCTK) | United States | $0.027B | |
| ACCURAY INC (ARAY) | United States | $0.027B | -0.63 |
| HeartBeam, Inc. (BEAT) | United States | $0.022B | -2.08 |
| SANUWAVE Health, Inc. (SNWV) | United States | $0.041B | 5.47 |
| RETRACTABLE TECHNOLOGIES INC (RVP) | United States | $0.021B | -6.44 |
| FEMASYS INC (FEMY) | United States | $0.020B | -1.07 |
| Modular Medical, Inc. (MODD) | United States | $0.018B | -0.88 |
| NEPHROS INC (NEPH) | United States | $0.046B | 23.02 |
| SeaStar Medical Holding Corp (ICU) | United States | $0.015B | -1.14 |